Silexion Therapeutics (SLXN) Stock Soars 61% After Hours: Here's What's Going On
Silexion Therapeutics shares jump after hours on positive SIL204 preclinical findings for KRAS-driven cancers.
Share
Why It Matters
Silexion shared early research results that looked really good for a cancer medicine. When you see a big jump like this, watch if the company can actually turn those early results into a real medicine people can use.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.